Heterologous Prime-Boost Vaccination Using an AS03(B)-Adjuvanted Influenza A(H5N1) Vaccine in Infants and Children <3 Years of Age

Background. Protecting young children from pandemic influenza should also reduce transmission to susceptible adults, including pregnant women. Methods. An open study assessed immunogenicity and reactogenicity of a heterologous booster dose of A/turkey/Turkey/1/2005(H5N1)-AS03(B) (AS03(B) is an Adjuv...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Nolan, Terry, Izurieta, Patricia, Lee, Bee-Wah, Chan, Poh Chong, Marshall, Helen, Booy, Robert, Drame, Mamadou, Vaughn, David W.
Formatua: Online Artikulua Texto
Hizkuntza:English
Argitaratua: Oxford University Press 2014
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224137/
https://www.ncbi.nlm.nih.gov/pubmed/24973461
http://dx.doi.org/10.1093/infdis/jiu359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224137/
https://www.ncbi.nlm.nih.gov/pubmed/24973461
http://dx.doi.org/10.1093/infdis/jiu359

Antzeko izenburuak